Russell Investments Group
CTKB icon

Russell Investments Group’s Cytek Biosciences CTKB Stock Holding History

Russell Investments Group’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.94M Buy
1,359,900
+358,773
+36% +$1.69M 0.01% 1261
2025
Q4 		$5.06M Buy
1,001,127
+841,614
+528% +$3.91M 0.01% 1321
2025
Q3 		$554K Buy
159,513
+131,718
+474% +$494K ﹤0.01% 2440
2025
Q2 		$94.5K Sell
27,795
-39,589
-59% -$132K ﹤0.01% 2832
2025
Q1 		$270K Buy
67,384
+39,582
+142% +$205K ﹤0.01% 2504
2024
Q4 		$180K Sell
27,802
-10,403
-27% -$62K ﹤0.01% 2563
2024
Q3 		$212K Buy
38,205
+29,845
+357% +$169K ﹤0.01% 2501
2024
Q2 		$46.6K Buy
8,360
+8,168
+4,254% +$49.1K ﹤0.01% 2778
2024
Q1 		$1.29K Buy
192
+71
+59% +$562 ﹤0.01% 3115
2023
Q4 		$1.1K Buy
+121
New +$762 ﹤0.01% 3054

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return